Cost-effectiveness of ticagrelor in acute coronary syndromes

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.13, Iss.1, 2013-02, pp. : 9-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Anticoagulation in Acute Coronary Syndromes

By Latour-Pérez Jaime de-Miguel-Balsa Eva

PharmacoEconomics, Vol. 30, Iss. 4, 2012-04 ,pp. : 303-321

Adis International

Access to resources Recommend Favorite

Review of ticagrelor in the management of acute coronary syndromes

By Burgess Sonya Mallard Trevor A Juergens Craig P

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1315-1325

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective

By Balen R.M.

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 533-542

Adis International

Access to resources Recommend Favorite

Ticagrelor: A Review of its Use in the Management of Acute Coronary Syndromes

By Deeks Emma D.

Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. : 909-933

Adis International

Access to resources Recommend Favorite

Ticagrelor: a guide to its use in the management of acute coronary syndromes

By Scott Lesley J. Deeks Emma D.

Drugs & Therapy Perspectives, Vol. 28, Iss. 1, 2012-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite